High-risk Human Papillomavirus Infection
3 clinical trials · Condition
◉ Watch High-risk Human Papillomavirus Infection
| Record | Firm | Date |
|---|---|---|
| A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV) (NCT07601074) | Daré Bioscience, Inc. | 2026-06-01 |
| Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus (NCT05918510) | Regina Elena Cancer Institute | 2022-04-04 |
| Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female (NCT04633330) | Shandong University | 2020-10-26 |
Track High-risk Human Papillomavirus Infection automatically
Every clearance here is in the API, with alerts when new ones post.